Lataa...
Autoimmune phenotypes in schizophrenia reveal novel treatment targets
Typical and atypical antipsychotics are the first-line treatments for schizophrenia, but these classes of drugs are not universally effective, and they can have serious side effects that impact compliance. Antipsychotic drugs generally target the dopamine pathways with some variation. As research of...
Tallennettuna:
| Julkaisussa: | Pharmacol Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097895/ https://ncbi.nlm.nih.gov/pubmed/29742478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2018.05.005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|